Radiochemoimmunotherapy for pancreatic cancerMÄRTEN, Angela; BÜCHLER, Markus W; SCHMIDT, Jan et al.The American journal of surgery. 2007, Vol 194, Num 4A, issn 0002-9610, S138-S142, SUPArticle

Interferon-oc Enhances Antitumor Effect of Chemotherapy in an Orthotopic Mouse Model for Pancreatic AdenocarcinomaYIFAN ZHU; TIBENSKY, Igor; SCHMIDT, Jan et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 7, pp 599-606, issn 1524-9557, 8 p.Article

Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivoSCHMIDT, Jan; KLEMPP, Christoph; BUCHLER, Markus W et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 1, pp 31-38, issn 0340-7004, 8 p.Article

Dendritic cells reduce number and function of CD4⁺CD25⁺ cells in cytokine-induced killer cells derived from patients with pancreatic carcinomaSCHMIDT, Jan; EISOLD, Sven; BÜCHLER, Markus W et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 11, pp 1018-1026, issn 0340-7004, 9 p.Article

Interferon-alpha Restitutes the Chemosensitivity in Pancreatic CancerHOFFMANN, Katrin; MEHRLE, Stefan; SCHMIDT, Jan et al.Anticancer research. 2008, Vol 28, Num 3A, pp 1499-1507, issn 0250-7005, 9 p.Article

Pankomab : a potent new generation anti-tumour MUC1 antibodyDANIELCZYK, Antje; STAHN, Renate; FAULSTICH, Dorian et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 11, pp 1337-1347, issn 0340-7004, 11 p.Article

Soluble iC3b as an Early Marker for Pancreatic Adenocarcinoma Is Superior to CA19.9 and RadiologyMÄRTEN, Angela; BÜCHLER, Markus W; WERFT, Wiebke et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 2, pp 219-224, issn 1524-9557, 6 p.Article

Impact of interferon-α in combined chemoradioimmunotherapy for pancreatic adenocarcinoma (CapRI) : First data from the immunomonitoringSCHMIDT, Jan; JÄGER, Dirk; HOFFMANN, Kartin et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 1, pp 108-115, issn 1524-9557, 8 p.Article

Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for δ2 γ/δ T cellsMÄRTEN, Angela; VON LILIENFELD-TOAL, Marie; BÜCHLER, Markus W et al.Journal of immunotherapy (1997). 2007, Vol 30, Num 4, pp 370-377, issn 1524-9557, 8 p.Article

Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinomaSIEVERS, Elisabeth; ALBERS, Peter; SCHMIDT-WOLF, Ingo G. H et al.The Journal of urology. 2004, Vol 171, Num 1, pp 114-119, issn 0022-5347, 6 p.Article

Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicityMÄRTEN, Angela; VON LILIENFELD-TOAL, Marie; BÜCHLER, Markus W et al.International journal of cancer. 2006, Vol 119, Num 10, pp 2359-2365, issn 0020-7136, 7 p.Article

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trialMÄRTEN, Angela; FLIEGER, Dimitri; KRIZEK, Ludmila et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 11-12, pp 637-644, issn 0340-7004, 8 p.Article

Intratumoral immunization with tumor RNA-pulsed dendritic cells confers antitumor immunity in a C57BL/6 pancreatic murine tumor modelSCHMIDT, Tanja; ZISKE, Carsten; MÄRTEN, Angela et al.Cancer research (Baltimore). 2003, Vol 63, Num 24, pp 8962-8967, issn 0008-5472, 6 p.Article

Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trialWITTIG, Burghardt; MÄRTEN, Angela; LÖFFEL, Jürgen et al.Human gene therapy. 2001, Vol 12, Num 3, pp 267-278, issn 1043-0342Article

5-Fluorouracil and Interferon-α Immunochemotherapy Enhances Immunogenicity of Murine Pancreatic Cancer Through Upregulation of NKG2D Ligands and MHC Class IKHALLOUF, Hadeel; MÄRTEN, Angela; SERBA, Susanne et al.Journal of immunotherapy (1997). 2012, Vol 35, Num 3, pp 245-253, issn 1524-9557, 9 p.Article

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cellsMÄRTEN, Angela; GRETEN, Tim; ZISKE, Carsten et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 1, pp 25-32, issn 0340-7004Article

Activating anti-CD40 antibodies induce tumour invasion by cytotoxic T-lymphocytes and inhibition of tumour growth in experimental liver cancerRYSCHICH, Eduard; MÄRTEN, Angela; SCHMIDT, Eduard et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 981-987, issn 0959-8049, 7 p.Article

Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivoSCHMIDT, Jan; RYSCHICH, Eduard; SIEVERS, Elisabeth et al.Cancer. 2006, Vol 106, Num 4, pp 759-764, issn 0008-543X, 6 p.Article

Allogeneic dendritic cells fused with tumor cells: Preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinomaMÄRTEN, Angela; RENOTH, Sabine; EIS-HÜBINGER, Anna M et al.Human gene therapy. 2003, Vol 14, Num 5, pp 483-494, issn 1043-0342, 12 p.Article

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cellsMÄRTEN, Angela; RENOTH, Sabine; VON LILIENFELD-TOAL, Marie et al.Haematologica (Roma). 2001, Vol 86, Num 10, pp 1029-1037, issn 0390-6078Article

Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populationsMÄRTEN, Angela; ZISKE, Carsten; SCHÖTTKER, Björn et al.Journal of immunotherapy (1997). 2001, Vol 24, Num 6, pp 502-510, issn 1524-9557Article

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linkedVON LILIENFELD-TOAL, Marie; FRANK, Susanne; COOK, Gordon et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 6, pp 829-839, issn 0340-7004, 11 p.Article

Interferon-α in Combination With Chemotherapy has Potent Antiangiogenic Properties in an Orthotopic Mouse Model for Pancreatic AdenocarcinomaYIFAN ZHU; TIBENSKY, Igor; SCHMIDT, Jan et al.Journal of immunotherapy (1997). 2008, Vol 31, Num 1, pp 28-33, issn 1524-9557, 6 p.Article

Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI)SCHMIDT, Jan; PATRUT, Emilia M; JIANHUA MA et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 11, pp 1396-1405, issn 0340-7004, 10 p.Article